Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnosis of Obstructive Sleep Apnoea by Selective Secondary Electrospray Ionization - Mass Spectrometry (SESIMS)

NCT02810158 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

NCT NCT02810158
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02810158 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnosis of Obstructive Sleep Apnoea by Selective Secondary Electrospray Ionization - Mass Spectrometry (SESIMS)
Lead sponsor
University of Zurich
Phase
Observational
Overall status
Completed
Start date
June 30, 2016
Completion date
May 31, 2018
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

exhaled breath, mass spectrometry, obstructive sleep apnoea (osa)